The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
暂无分享,去创建一个
J. Bartek | J. Lukas | J. Bártková | P. Guldberg | J. Alsner | J. Zeuthen | J Lukas | J Bartek | J Alsner | J Bartkova | P Guldberg | J Zeuthen | A F Kirkin | A. Kirkin
[1] R. Weinberg,et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Pagano,et al. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. , 1994, Oncogene.
[3] L. Sandkuijl,et al. Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds , 1995, Nature Genetics.
[4] A. Okamoto,et al. IS-12 Mutation and altered expression of P16^ in human cancer. , 1995 .
[5] L. Lerman,et al. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. , 1987, Methods in enzymology.
[6] F. Haluska,et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. , 1995, Cancer research.
[7] J. Bartek,et al. Unrestricted cell cycling and cancer , 1995, Nature Medicine.
[8] P. Pollock,et al. Evidence for u.v. induction of CDKN2 mutations in melanoma cell lines. , 1995, Oncogene.
[9] M. Strauss,et al. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. , 1995, Cancer research.
[10] James M. Roberts,et al. Inhibitors of mammalian G1 cyclin-dependent kinases. , 1995, Genes & development.
[11] A. Hart,et al. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.
[12] J. Bartek,et al. Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control. , 1995, Cancer research.
[13] R. Weinberg,et al. Growth suppression by p16ink4 requires functional retinoblastoma protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Bartek,et al. Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells. , 1996, Oncogene.
[15] A. Arnold,et al. Cyclins and oncogenesis. , 1993, Biochimica et biophysica acta.
[16] G. Peters,et al. Lack of cyclin D‐Cdk complexes in Rb‐negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product. , 1995, The EMBO journal.
[17] K. Keyomarsi,et al. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. , 1991, Cancer research.
[18] C. O'keefe,et al. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. , 1994, Genes & development.
[19] D. Carson,et al. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers , 1994, Nature.
[20] V. Stanton,et al. Use of denaturing gradient gel electrophoresis to study conformational transitions in nucleic acids. , 1992, Methods in enzymology.
[21] M. Skolnick,et al. A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.
[22] M. Skolnick,et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus , 1994, Nature Genetics.
[23] F. Kaye,et al. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. , 1994, Oncogene.
[24] W. Clark,et al. Germline p16 mutations in familial melanoma , 1994, Nature Genetics.
[25] E. Hovig,et al. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas. , 1996, British Journal of Cancer.
[26] J. Bartek,et al. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death , 1997, Nature Medicine.
[27] A. Hogg,et al. Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. , 1992, Oncogene.
[28] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[29] B. Dynlacht,et al. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition , 1995, Nature.
[30] R. Weinberg,et al. The retinoblastoma protein and cell cycle control , 1995, Cell.
[31] L. Sandkuijl,et al. CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple‐mole melanoma (FAMMM) syndrome families , 1995, Melanoma research.
[32] G. Hannon,et al. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 , 1993, Nature.
[33] J. Bartek,et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.
[34] J. Bartek,et al. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1 , 1994, The Journal of cell biology.
[35] E. Schuuring,et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. , 1995, Blood.
[36] D. Becker,et al. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system. , 1996, Oncogene.
[37] J. A. Bishop,et al. Retinoblastoma, melanoma and the atypical mole syndrome , 1995, The British journal of dermatology.
[38] A. Kamb,et al. Cell-cycle regulators and cancer. , 1995, Trends in genetics : TIG.
[39] J. Bartek,et al. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. , 1995, Oncogene.
[40] J. Shay,et al. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. , 1994, Cancer research.
[41] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[42] R. Saxton,et al. Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice , 2004, Journal of Cancer Research and Clinical Oncology.